<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" version="2.0"><channel><title>Anatoli Kamali</title><link>https://www.scidev.net/sub-saharan-africa/rss.xml/?type=author&amp;rssname=anatoli-kamali</link><description>Anatoli Kamali RSS feeds.</description><pubDate>Sun, 9 Aug 2026 02:08:14 GMT</pubDate><language>en</language><atom:link rel="self" type="application/rss+xml" href="https://www.scidev.net/sub-saharan-africa/rss.xml/?type=author&amp;rssname=anatoli-kamali"/><item><title>Africa Analysis: Capacity building in HIV vaccine R&amp;#038;D</title><link>https://www.scidev.net/sub-saharan-africa/column/capacity-building-hiv-vaccine/</link><guid>https://www.scidev.net/sub-saharan-africa/column/capacity-building-hiv-vaccine/</guid><description>African scientists are spearheading HIV vaccine R&amp;D but new investments are needed, writes Anatoli Kamali. 
</description><pubDate>Fri, 18 May 2018 06:05:17 GMT+0000</pubDate><enclosure url="https://www.scidev.net/sub-saharan-africa/wp-content/uploads/sites/5/2019/08/health_care_prepares_a_measles_vaccine.jpg" length="1000" type="image/jpeg"/><dc:creator>Anatoli Kamali</dc:creator></item></channel></rss>
